¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2018³â Á¦ 13Â÷ ´ëÇѹé½ÅÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-28

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
​2018³â Á¦ 13Â÷ ´ëÇѹé½ÅÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-28
±³À°ÀÏÀÚ : 2018-09-28
±³À°Àå¼Ò : °¡Å縯ÀÇ´ë ¼ºÀÇȸ°ü ¸¶¸®¾ÆȦ  
±³À°ÁÖÁ¦ : 2018³â Á¦ 13Â÷ ´ëÇѹé½ÅÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѹé½ÅÇÐȸ(ÀÎ)
´ã´çÀÚ : ÀÌ¿µ¼ö
¿¬¶ôó : 02-2258-7472  
À̸ÞÀÏ : office@korvac.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, À̺ñÀÎÈÄ°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í È¸¿ø »çÀüµî·Ï µî±Þº° 3¸¸¿ø, 5¸¸¿ø, ºñȸ¿ø »çÀüµî·Ï 8¸¸¿ø ȸ¿ø ÇöÀåµî·Ï µî±Þº° 5¸¸¿ø, 7¸¸¿ø, ºñȸ¿ø ÇöÀåµî·Ï 10¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 08:30~09:00 Opening  °­ÁøÇÑ(°¡Å縯´ë ¼Ò¾Æû¼Ò³â°ú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 09:00~09:20 MiRNA-150-mediated Foxo1 Regulation Programs CD8+ T cell Differentiation  ÇÏ»óÁØ(¿¬¼¼´ë »ýÈ­Çаú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 09:20~09:40 Modulation of T cell immunity using cell-penetrating peptide for treating inflammatory diseases, cancer and vaccine development  ÃÖÁ¦¹Î(ÇѾç´ë) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 09:40~10:00 NOX2-mediated ROS Generation in Macrophages via Endocytosis of Monomeric TLR4-MD2 Complex in Non-Alcoholic Fatty Liver Disease  Á¤¿øÀÏ(KAIST) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 10:00~10:20 Cancer Immunotherapy with Engineered Salmonella typhimurium secreting Heterologous Flagellin  ÀÌÁØÇà(Àü³²´ë ¹Ì»ý¹°Çб³½Ç) 
È޽Ġ09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 10:20~10:40 È޽Ġ () 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 10:40~11:00 The Korean Influenza National Immunization Program: Overview  Á¤ÈñÁø(°í·Á´ë °¨¿°³»°ú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 11:00~11:20 From Vaccine Import to Self-Reliance: Looking Back on the Development  ÃÖ´öÈ£(Çѱ¹¹é½Å) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 11:20~11:40 Pandemic Preparedness  ¹®»óÁØ(Áúº´°ü¸®º»ºÎ) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 11:40~12:20 A New Paradigm for Immunologists: The Protein-Homeostasis-System Hypothesis  ÀÌ°æÀÏ(°¡Å縯ÀÇ´ë ¼Ò¾Æû¼Ò³â°ú) 
±âŸ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 12:20~12:50 ´ëÇѹé½ÅÇÐȸ ÃÑȸ  () 
½Ä»ç 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 12:50~13:40 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 13:40~14:00 Updated Approval Regulation about Vaccine: Focus on Risk Management Plan and Information for Experts  ±èµµ±Ù(½ÄÇ°ÀǾàÇ°¾ÈÀüó) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 14:00~14:20 Evaluation of Quadrivalent Influenza Vaccine Clinical Trials  °ûº´¿Á(½ÄÇ°ÀǾàÇ°¾ÈÀüó) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 14:20~14:40 Vaccine against Mycoplasma  ÀÌ»ó¿ø(°Ç±¹´ë ¼öÀÇÇаú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 14:40~15:00 Foot and Mouth Disease Vaccine  ÀÌÁ¾¼ö(Ãæ³²´ë ¼öÀǹ̻ý¹°Çб³½Ç) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 15:00~15:20 PCV2 vaccine  Ã¤ÂùÈñ(¼­¿ï´ë ¼öÀÇÇаú) 
È޽Ġ09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 15:20~15:40 È޽Ġ () 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 15:40~16:00 Staphylococcus aureus Vaccine  ±è¾ç¼ö(¿ï»ê´ë °¨¿°³»°ú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 16:00~16:20 Clostridium difficile Vaccine  ±èÁöÀº(ÇѾç´ë °¨¿°³»°ú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 16:20~16:40 HIV/AIDS Vaccine  ½Å¼Ò¿¬(°¡Å縯°üµ¿´ë °¨¿°³»°ú) 
±³À°½Ã°£ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 16:40~17:30 Poster Presentation Session  À̵¿°Ç(°¡Å縯´ë °¨¿°³»°ú) 
±âŸ 09¿ù 28ÀÏ °¡Å縯´ëÇб³ ¼ºÀÇȸ°ü 1Ãþ ¸¶¸®¾ÆȦ 17:30~17:40 Closing  ±è¿ìÁÖ(°í·Á´ë °¨¿°³»°ú) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2018³â Á¦ 13Â÷ ´ëÇѹé½ÅÇÐȸ Ãß°èÇмú´ëȸ : 2018-09-28""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û µ¿±¹´ëÇб³Àϻ꺴¿ø new concepts in elbow dislocation and clinical application : 2018-09-28
´ÙÀ½±Û ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ÀÎÁöÇൿġ·á : 2018-09-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 37 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 35 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 31 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 27 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 31 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 47 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 17 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 25 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 24 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 24 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 22 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 20 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 23 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 28 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 28 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷